These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36641903)

  • 1. The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
    Orellana TJ; Garrett AA; Soong TR; Rives T; Courtney-Brooks M; Taylor SE; Lesnock J; Berger J; Boisen M; Coffman L; Buckanovich R; Mahdi H; Comerci JC; Beriwal S; Sukumvanich P; Edwards RP; Bhargava R; Olawaiye AB
    Gynecol Oncol; 2023 Mar; 170():77-83. PubMed ID: 36641903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.
    Kurnit KC; Nobre SP; Fellman BM; Iglesias DA; Lindemann K; Jhingran A; Eriksson AGZ; Ataseven B; Glaser GE; Mueller JJ; Westin SN; Soliman PT
    Gynecol Oncol; 2022 Dec; 167(3):452-457. PubMed ID: 36243601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
    Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
    Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy of uterine clear cell carcinoma: a review.
    Xu Y; Hanna RK; Elshaikh MA
    Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
    Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM
    Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
    Armbruster SD; Previs R; Soliman PT; Westin SN; Fellman B; Jhingran A; Fleming ND
    Gynecol Oncol; 2019 Aug; 154(2):328-332. PubMed ID: 31221496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
    Xiang M; English DP; Kidd EA
    Gynecol Oncol; 2019 Mar; 152(3):599-604. PubMed ID: 30551884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study.
    Kim M; Kwon BS; Chang HK; Lee S; Chang SJ; Choi JY; Park SY; Lee M; Ryu HS; Kim YB
    J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis.
    Qu XM; Velker VM; Leung E; Kwon JS; Elshaikh MA; Kong I; Logie NA; Mendez LC; van der Putten LJ; Donovan EK; Munkarah AR; Wiebe EM; Parra-Herran C; Warner A; Louie AV; D'Souza DP
    Gynecol Oncol; 2018 May; 149(2):283-290. PubMed ID: 29544706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
    Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
    Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
    Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
    Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
    Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
    Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes.
    Yuce Sari S; Guler OC; Oymak E; Gultekin M; Yigit E; Kahvecioglu A; Yuce K; Celik H; Usubutun A; Bolat F; Onal C; Yildiz F
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1876-1887. PubMed ID: 35385171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas.
    Sherertz T; Jhingran A; Biagioli M; Gaffney D; Elshaikh M; Coleman RL; Harkenrider M; Kidd EA; Jolly S; Yashar C; Portelance L; Wahl A; Venkatesan A; Li L; Small W;
    Int J Gynecol Cancer; 2022 Dec; 32(12):1549-1554. PubMed ID: 36423958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
    Lefebvre M; Duchatelet M; El Hajj H; De Courrèges A; Wallet J; Bellier C; Le Tinier F; Le Deley MC; Martinez Gomez C; Leblanc E; Narducci F; Hudry D
    Curr Oncol; 2023 Jan; 30(1):1174-1185. PubMed ID: 36661739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
    Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
    Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
    Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
    J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.